Lyashchenko K P, Greenwald R, Esfandiari J, Meylan M, Burri I Hengrave, Zanolari P
Chembio Diagnostic Systems Inc, Medford, NY 11763, USA.
Vet Microbiol. 2007 Dec 15;125(3-4):265-73. doi: 10.1016/j.vetmic.2007.05.026. Epub 2007 Jun 13.
Antibody responses in New World camelids (NWC) infected with Mycobacterium microti were studied by two serological methods, multiantigen print immunoassay (MAPIA) and lateral-flow-based rapid test (RT). Serum samples were collected during 2004-2006 from 87 animals including 1 alpaca and 7 llamas with confirmed or suspected M. microti infection, 33 potentially exposed but clinically healthy animals from known infected herds, and 46 control NWC from herds where infection had not been previously diagnosed. The serological assays correctly identified infection status in 97% (MAPIA) or 87% (RT) cases. In three llamas with confirmed M. microti infection and one llama with gross pathology suggestive of disease, for which multiple serum samples collected over time were available, the antibody-based tests showed positive results 1-2 years prior to the onset of clinical signs or being found dead. In MAPIA, MPB83 protein was identified to be an immunodominant serological target antigen recognized in NWC infected with M. microti. With the limited number of animals tested in this study, the serological assays demonstrated the potential for convenient, rapid, and accurate diagnosis of M. microti infection in live llamas and alpacas.
采用多抗原印迹免疫分析(MAPIA)和基于侧流技术的快速检测(RT)这两种血清学方法,对感染微小分枝杆菌的新大陆骆驼科动物(NWC)的抗体反应进行了研究。在2004年至2006年期间,从87只动物身上采集了血清样本,其中包括1只羊驼和7只美洲驼,它们已确诊或疑似感染微小分枝杆菌;33只来自已知感染畜群、可能接触过病原体但临床健康的动物;以及46只来自此前未诊断出感染的畜群的对照NWC。血清学检测在97%(MAPIA)或87%(RT)的病例中正确识别了感染状态。在3只确诊感染微小分枝杆菌的美洲驼和1只具有明显疾病病理特征的美洲驼中,随着时间推移采集了多个血清样本,基于抗体的检测在临床症状出现或被发现死亡前1至2年呈阳性结果。在MAPIA中,MPB83蛋白被确定为感染微小分枝杆菌的NWC中识别出的一种免疫显性血清学靶抗原。鉴于本研究中检测的动物数量有限,血清学检测证明了在活体美洲驼和羊驼中方便、快速且准确地诊断微小分枝杆菌感染的潜力。